Related Experiment Video
Updated: Nov 20, 2025
09:16
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.5K
[STIGMA AND MISINFORMATION ABOUT METHADONE MAINTENANCE THERAPY].
Lihi Rozner1, Einat Peles2,3,4
1Department of Psychiatry, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Harefuah
|January 21, 2021
Summary
Methadone maintenance therapy is effective for opioid addiction but faces low uptake due to stigma and misinformation. Addressing these barriers is crucial for improving treatment access and outcomes for patients with opioid use disorder.
Area of Science:
- Addiction medicine
- Public health
- Mental health
Background:
- Opioid abuse presents a significant socio-economic and health challenge with high morbidity and mortality.
- Methadone maintenance therapy (MMT), combined with psychosocial support, is the leading treatment for opioid addiction.
- Low patient engagement with MMT is observed, often with significant delays in seeking treatment.
Purpose of the Study:
- To explore the reasons behind the delayed and low uptake of methadone maintenance therapy.
- To identify the roles of stigma and misinformation in hindering MMT access for individuals with substance use disorder.
Main Methods:
- Literature review of studies on methadone maintenance therapy.
- Analysis of factors influencing treatment-seeking behavior in opioid addiction.
- Examination of societal, familial, and professional perspectives on MMT.
Main Results:
- Stigma and misinformation are frequently cited as major barriers to MMT.
- Patients, families, and healthcare professionals may hold negative perceptions of methadone treatment.
- Delayed treatment seeking is linked to a lack of accurate information and societal judgment.
Conclusions:
- Overcoming stigma and misinformation is essential to increase MMT accessibility.
- Educational interventions targeting patients, families, and healthcare providers are needed.
- Improving public and professional understanding of MMT can enhance treatment rates for opioid addiction.
More Related Videos
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.4K
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
10.0K
Related Concept Videos
01:17Phase II Reactions: Methylation Reactions
509
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
509
01:29Therapeutic Drug Monitoring: Affecting Factors
88
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
88
01:15Drug Abuse and Addiction: Pharmacological Phenomena
924
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
924
01:25Analgesia and Pain Management
1.2K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.2K
01:17Drug Dependence
1.4K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.4K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
661
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
661